Post on 01-Jan-2017
transcript
Sharekhan Special October 10, 20161
Sharekhan Special Q2FY2017 earnings preview
Visit us at www.sharekhan.com October 10, 2016
Q2FY2017 to be another weak quarter: The headline growth figures for the Sensex companies do not inspire much confidence in Q2FY2017 also. The aggregate net profit of the Sensex companies is likely to remain flat in the quarter despite a mid-single digit growth in the revenue and a margin expansion of close to 50 basis points as compared with the corresponding quarter of the last year. However, excluding the financials, the growth in the Sensex companies would stand at 3.5% in Q2FY2017.
Banking, technology and metal lag; auto, FMCG and pharma to post a healthy performance: In terms of sector-wise performance, the earnings growth is likely to be pulled down by the usual suspects, ie the information technology (IT) services companies (weak demand resulted in a weak performance in a seasonally strong quarter), banks (ICICI Bank, Axis Bank and State Bank of India [SBI] to show a decline in the net profit) and metals (Tata Steel, largely due to foreign exchange [forex] impact and weak demand). On the other hand, auto companies continue to race ahead while the fortunes have turned for the pharmaceutical (pharma) sector. The consumer staples space is likely to sustain its high double-digit growth rate in Q2 also.
Outlook
Turn-around to be driven by cyclicals: Notwithstanding the weak results in the first two quarters of FY2017, the Street is still factoring in a healthy double-digit earnings growth in the aggregate profit of the Sensex companies which implies a strong recovery in the earnings growth in the second half of the fiscal. The biggest turn-around in the earnings growth trajectory is expected to be driven by banks (due to a low base owing to the balance
Q2FY2017 earnings previewWeakness to continue in Q2 also but earnings growth set to turn around in the coming quarters
sheet cleaning exercise triggered in Q3 last year and a possible bottoming of the asset quality issues in H1 this year) and global commodity-driven metal and energy companies (again due to a lower base and some upsurge in commodity prices lately). More importantly, the benefits of a good monsoon-driven record agricultural output and salary hikes for the government employees would get reflected in the second half of this year.
Valuation
The Sensex trades at a price/earnings (PE) multiple of close to 16.5-17.0x on a one-year forward basis which is at a premium to its historic multiple. However, this needs to be seen in the context of extremely low interest rates globally and falling interest rates and bond yields in India. Normally, lower interest rates tend to expand the PE multiple, though the growth in the earnings remains the key re-rating driver for the equity market. Thus, a revival in the earnings growth remains a critical factor for the sustainability of the rally in Indian equities.
Sensex’ one-year forward P/E band
Source: Bloomberg, Sharekhan Research
7.0
10.0
13.0
16.0
19.0
22.0
25.0
Oct
-08
Oct
-10
Oct
-12
Oct
-14
Oct
-16
+1 sd PER Avg PER -1 sd
Sharekhan Special October 10, 20162
Sharekhan Special Q2FY2017 earnings preview
Estimated PAT growth by sector (%) Estimated sector-wise contribution to Sensex’ earnings growth (%)
Source: Bloomberg, Sharekhan Research Source: Bloomberg, Sharekhan Research
Sensex earnings (EPS) consensus estimates Estimated revenue growth by sector (%)
Source: Bloomberg Source: Bloomberg, Sharekhan Research
Leaders Laggards
Glenmark, Lupin and Sun Pharma Cipla, Torrent Pharma
Britannia, Jyothy Laboratories, Kansai Nerolac, Zydus Wellness GSK Consumer, Emami, KDDL, Exports
HDFC Bank, Capital First, LIC Housing Finance,Bajaj Finance Bank of India, IDBI Bank, Allahabad Bank
V-Guard, Finolex Cables, RIL Thermax, Va tech Wabag
Infosys, HCL Tech, Zee Entertainment Wipro, Inox Leisure
Maruti Suzuki, TVS Motors Bajaj Auto , Ashok Leyland
13.5 11.79.2 8.6 8.4 7.3
4.01.8
-4.0 -4.9
4.5
-10.0
-5.0
0.0
5.0
10.0
15.0
20.0
Auto
Cap.
goo
ds IT
Phar
ma
FMCG BFSI
Powe
r
Tele
com
Met
al
Dive
rsifie
d
Sens
ex
75.4
46.3
19.1 14.8 11.7 11.2 10.11.5
-13.4-18.1
-0.5
-40.0
-20.0
0.0
20.0
40.0
60.0
80.0
Cap
. goo
ds
Met
al
Phar
ma
Tele
com
Auto
FMC
G
Div
ersi
fied IT
BFSI
Pow
er
Sens
ex
1.2
-0.5
1.20.9
0.70.6 -0.4 -0.6 -0.6
-0.9- 1.2
-1.6
-3.0
-1.0
1.0
3.0
5.0
7.0
Div
ersi
fied
Auto
Phar
ma
FMC
G
Cap
. goo
ds IT
Tele
com
Ener
gy
Pow
er
Met
al
BFSI
Sens
ex
1400.00
1500.00
1600.00
1700.00
1800.00
1900.00
2000.00
2100.00
2200.00
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb-
16
Mar
-16
Apr-
16
May
-16
Jun-
16
Jul-1
6
Aug-
16
Sep-
16
Oct
-16
FY17 EPS Estimate FY18 EPS Estimate
Sharekhan Special October 10, 20163
Sharekhan Special Q2FY2017 earnings preview
AutoVolume growth to drive earnings
Q2FY2017 result expectations
Improved rural sentiment coupled with the onset of the festive season to lead to a double-digit top line growth: Sharekhan’s automobile universe (ex Tata Motors [TAMO]) is expected to register a healthy double-digit top line growth of 14% year on year (YoY) driven mainly by a volume growth. Improved rural sentiment on the back of a normal monsoon and improved demand ahead of the upcoming festive season has led to a healthy volume growth in the automotive segment (ex medium and heavy commercial vehicles [MHCVs]). Maruti Suzuki India and Eicher Motors are expected to lead the space with a growth of 31% and 35% YoY. Ashok Leyland (due to declining MHCV volumes) and Bajaj Auto (due to a dip in the export volumes) are expected to post a drop in the top line. In the auto ancilliary space, Exide Industries and Suprajit Engineering are expected to outperform, growing by 18% and 15% respectively, on the back of better demand traction from the end-users. Bharat Forge (due to weak export demand) and Jamna Auto Industries (due to declining sales of MHCV original equipment) are likely to underperform reporting a 7% top line dip.
Increasing raw material prices and input pressures to lead to a marginal dip in the OPM: The operating profit margin (OPM) of Sharekhan’s automobile universe (ex TAMO) is expected to decline by 60 basis points (BPS) YoY to 15.4% for the quarter. The firming up of the prices of raw materials (especially steel) is likely to affect the profitability of the auto companies. Further, increased marketing expenses (due to increased competition and the onset of festive season) would also drag the profitability. Amongst the auto companies Eicher Motors, Exide Industries and Suprajit Engineering are expected to report a remarkable improvement in the operating profit margin (OPM; up 300BPS, 100BPS and 100BPS YoY respectively) while Maruti Suzuki India and Bajaj Auto could report a decline in their OPM by 180BPS and 80BPS YoY respectively. The hardening natural rubber prices are expected to adversely affect the margins of the tyre players including Apollo Tyres, Ceat and Balkrishna Industries whose margins would contract by 200BPS, 230BPS and 280BPS YoY respectively. Tracking the top line growth and margin performance the adjusted profit after tax (PAT) of the auto universe (ex TAMO) is expected to grow by 14% YoY.
Outlook
The south-west monsoon for 2016 was well spread out and normal (a 3% deficiency observed) after two consecutive years of drought. This has led to a positive rub-off effect on the automobile demand, especially from the rural areas (an uptick was witnessed in two-wheeler and passenger vehicle sales). In addition to the improved rural sentiment, the hike in the salaries of the government employees based on the recommendation of the Seventh Pay Commission and the upcoming festive season are expected to maintain the growth momentum in the passenger vehicle and two-wheeler sales. We expect the two-wheeler sales to grow by 15% in FY2017 while the passenger vehicle segment is expected to grow by 8% to 10% in FY2017. The MHCV segment, though has reported weak sales for the quarter, is expected to pick up in H2FY2017 on the back of an improved demand for transportation of agri-products and a pre-buying ahead of the new emission norms kicking in from April 1, 2017.
Valuation
In the automotive universe, we prefer Mahindra and Mahindra (M&M) as it is a pure rural play and would be the key beneficiary of the impending uptick in rural demand due to a good monsoon. We also prefer Maruti Suzuki India, as it would outpace the passenger vehicle industry in growth on the back of a robust demand for its newly launched products. We also like Ashok Leyland, as it is a pure commercial vehicle (CV) play and would benefit from a strong demand for CVs. In the auto ancillary space we prefer Rico Auto Industries (due to an increasing customer penetration and margin improvement) and Gabriel India due to a strong traction in the two-wheeler volumes.
Preferred picks for the earning season: Maruti Suzuki, TVS Motors and Rico Auto Industries
Sharekhan Special October 10, 20164
Sharekhan Special Q2FY2017 earnings preview
Q2FY2017 estimates of Sharekhan’s auto universe
ParticularsSales (Rs Cr) EBITDA margins (%) PAT (Rs Cr)
Q2 FY17E
Q2 FY16
YoY%
QoQ %
Q2 FY17E
Q2 FY16
YoYBPS
QoQ BPS
Q2 FY17E
Q2 FY16
YoY%
QoQ%
Maruti Suzuki 18,276.6 13,933.7 31.2 22.4 14.5 16.3 (183.2) (38.8) 1,535.0 1,225.6 25.2 3.3
Hero MotoCorp 7,807.3 6,837.1 14.2 5.5 16.2 15.8 30.5 (47.4) 901.4 772.1 16.8 2.1
Bajaj Auto 5,992.8 6,097.8 (1.7) 4.3 20.8 21.6 (81.7) 31.7 970.0 933.1 4.0 (0.9)
TVS Motors 3,354.4 2,880.7 16.4 16.4 7.7 7.4 33.5 73.7 141.9 116.4 21.9 17.0
M&M # 10,036.9 8,793.7 14.1 (4.6) 13.2 13.2 (6.9) (99.1) 1,032.7 978.1 5.6 18.6
Ashok Leyland 4,530.7 4,939.7 (8.3) 6.4 12.3 12.0 23.7 108.8 298.5 292.0 2.2 23.8
Apollo Tyres @* 3,442.8 2,995.9 14.9 4.2 14.1 16.1 (205.6) (225.0) 269.6 231.0 16.7 (14.3)
Greaves Cotton 456.9 424.7 7.6 14.0 17.0 17.9 (86.1) 193.5 56.0 55.6 0.6 27.0
Gabriel 427.5 375.2 14.0 15.4 9.1 8.8 36.2 (10.5) 22.5 19.4 15.8 15.0
Rico Auto @ 278.2 243.8 14.1 2.4 11.7 11.0 66.1 (60.3) 14.9 10.5 42.1 (7.2)
Soft coverage
Tata Motors @ 67,952.2 61,318.2 10.8 3.1 13.1 11.2 185.6 32.5 2,410.6 2,223.2 8.4 (10.8)
Eicher Motors @ 1,763.0 1,301.2 35.5 13.3 30.7 27.7 297.6 46.3 404.6 255.5 58.4 7.5
Exide Industries 2,051.8 1,739.0 18.0 2.0 15.8 14.8 103.5 17.8 198.4 156.1 27.1 1.2
Bharat Forge 1,040.0 1,116.8 (6.9) 15.0 28.2 28.8 (63.0) 112.9 155.2 175.1 (11.3) 27.2
Suprajit Engg 300.9 262.4 14.7 18.3 16.5 15.5 101.0 43.0 24.8 20.1 23.7 26.0
Ceat @ 1,469.7 1,409.4 4.3 (0.0) 12.0 14.3 (234.9) (61.3) 97.5 107.4 (9.2) (6.3)
Balkrishna Industries 868.1 786.9 10.3 (6.5) 28.0 30.8 (283.8) (6.0) 127.2 125.0 1.7 (14.7)
Jk Tyres @* 1,839.8 1,810.2 1.6 3.3 19.0 17.0 205.2 (102.9) 123.1 118.3 4.0 22.7
Jamna Auto Industries @ 295.5 317.7 (7.0) (11.8) 12.9 11.3 159.0 (290.0) 12.3 15.3 (19.9) (55.3)
Minda Industries* 896.9 651.7 37.6 17.0 9.8 9.7 15.6 39.9 36.0 26.1 38.2 32.6
Auto Universe 133,081.9 118,235.9 12.6 5.6 14.2 13.5 70.0 3.3 8,832.2 7,855.6 12.4 0.4
Auto universe (ex TAMO) 65,129.7 56,917.7 14.4 8.4 15.4 16.0 (58.3) (34.6) 6,421.6 5,632.4 14.0 5.3
# MM+MVML ; @ Consolidated; * not comparable due to corporate actions
Valuations
Company CMP (Rs)EPS (Rs) PE (x)
Old reco New Reco PT (Rs)FY16 FY17E FY18E FY16 FY17E FY18E
Maruti Suzuki 5,712 151.3 210.8 255.6 37.7 27.1 22.3 Buy Buy 5,790 Hero MotoCorp 3,479 154.0 182.1 205.5 22.6 19.1 16.9 Buy Buy 4,100 Bajaj Auto 2,867 126.3 141.6 162.5 22.7 20.2 17.6 Hold Hold 3,150 TVS Motors 389 9.2 11.3 16.5 42.3 34.4 23.6 Hold Buy UR M&M @ 1,378 53.0 61.7 77.5 26.0 22.3 17.8 Buy Buy 1,580 Ashok Leyland 81 3.9 4.9 5.8 20.8 16.5 14.0 Buy Buy 105Apollo Tyres # 224 20.5 19.9 22.9 10.9 11.3 9.8 Buy Buy 245Greaves Cotton 128 7.4 7.6 8.6 17.3 16.8 14.9 Buy Buy 160Gabriel India 121 5.3 5.8 7.3 22.9 20.9 16.6 Hold Buy 130Rico Auto Industries # 69 2.5 4.2 5.2 27.4 16.4 13.3 Buy Buy 72Soft coverageTata Motors # 562 36.6 50.5 58.4 15.4 11.1 9.6 Positive PositiveEicher Motors* # 25,835 470.7 612.9 783.1 54.9 42.2 33.0 Neutral NeutralExide Industries 193 7.3 8.3 9.6 26.4 23.3 20.1 Neutral NeutralBharat Forge 940 30.3 25.3 33.0 31.0 37.2 28.5 Neutral NeutralSuprajit Engineering # 212 5.2 7.7 9.8 40.8 27.5 21.6 Neutral NeutralCEAT # 1,372 113.2 85.3 112.7 12.1 16.1 12.2 Neutral PositiveBalkrishna Industries 1,106 58.7 54.8 63.4 18.8 20.2 17.4 Positive NeutralJK Tyre & Industries # 152 20.4 16.4 19.0 7.5 9.3 8.0 Neutral NeutralJamna Auto Industries# 226 8.9 12.5 14.3 25.4 18.1 15.8 Positive NeutralMinda Industries 335 13.5 16.8 23.0 24.8 19.9 14.6 - Positive*FY16 for 15 Months; @ MM+MVML; # Consolidated Nos; UR- Under review
Sharekhan Special October 10, 20165
Sharekhan Special Q2FY2017 earnings preview
Q2FY2017 result expectations
Incremental slippages expected to be lower: Coming after couple of challenging quarters, when asset quality pressures increased sharply, Q2FY2017 will be a significant quarter, as overall performance of the banks is likely to improve a tad (relatively speaking). Lower intensity in incremental stressed assets [due to the RBI’s Asset Quality Review (AQR) and conservative internal assessment] is expected to have frontloaded NPL formation. As a result, we expect a decline in slippage run-rate compared to the previous quarters, although the same is expected to remain above normal.
Subdued credit growth; Retail only bright spot: As per the latest RBI data, non-food credit growth remained at sub-10% levels, owing to weak corporate demand and feeble capex revival. However, the retail loan book has shown good traction with a growth of ~18%. Retail loan segment growth has been driven by Housing, Vehicle Loans, Consumer Durable Financing and Personal Loans. We expect State Bank of India (SBI) and Bank of Baroda (BOB) to perform relatively better in the PSB space while private banks like HDFC Bank, Yes Bank and IndusInd Bank are expected to show better results. Few private sector banks like Axis Bank and ICICI Bank (having considerable exposure to Corporates & Project Loans) could end up reporting weak a performance during the quarter.
Comfortable liquidity, softening interest rate cycle indicate stable margins: Q2FY2017 witnessed adequate liquidity position, with the RBI taking a liquidity-neutral stance. During the quarter, most banks have not made any significant cut in their base rates while the deposit rates have declined, which is a margin accretive situation. Also, the quantum of interest rate reversals (as a result of high slippages) in Q1 & Q4 should see relatively lesser impact. However, a weak growth in high-yielding Corporate Loan book and a tilt towards Retail Lending (especially Home Loans) could impact overall yields. Therefore, we expect Net Interest Margins (NIM) to remain stable during Q2FY2017, as these factors will largely cancel each other out.
Non-interest income could be boosted by treasury gains: Indian bond yields have declined by ~60BPS during the quarter, which potentially allows banks to book profit. Since the RBI has conducted several OMOs (Open Market Operations) during the quarter, banks had the option to book profit on HTM category investment portfolio as well. We believe that banks may choose to utilise treasury profits to offset higher NPL and general provisions to augment their balance sheets. At the same time, we expect the fee income growth to remain tepid, as the Corporate Loan segment continues to struggle. The retail fee sub-segment should report a healthy uptick. Notably, ICICI Bank could see a sharp rise in Other Income due to stake sale in its insurance subsidiaries, which it could use to cover up its stressed book.
NBFC sector expected to benefit from softening rates, credit demand: We expect NBFCs (especially consumption / retail focused ones) to post strong Q2FY2017 results, aided by strong loan demand and improving scale / efficiency benefits. Decline in wholesale lending rates, which leads to cheaper Cost of Funds (CoF), is another positive for NBFCs. We expect strong traction in Consumer Durables, Home Loans, LAP, SME and MFI segments. As a result, NBFCs like Bajaj Finance, Capital First and LIC Housing Finance are expected to report strong Q2FY2017 results.
Outlook
We expect the quarter to be an important indicator on the extent of bad loan problem left in the system. Also, Q2FY2017 is expected to be a mixed bag, as the Corporate Loan segment continues to struggle although the Retail segment is expected to show better traction. We expect loan book growth to pick up from H2FY2017, with improving economic scenario, improvement in rural demand (due to good monsoon) and consumption driven growth from urban areas ( helped by implementation of 7th Central Pay Commission payouts and OROP).
Valuation
We find that valuations for PSBs have improved, as investors have started building in the end of the correction phase. We also believe that differentiated/well run PSBs like SBI and BOB will eventually gain market share at the expense of other PSBs and may justify a premium pricing. At the current levels, select NBFCs like LIC Housing Finance and Capital First are available at a discount to their peers and have attractive business model.
Preferred picks: HDFC Bank, Yes Bank, IndusInd Bank, Capital First and LIC Housing Finance
Earnings outperformers in Q2FY2017: HDFC Bank, Capital First, LIC Housing Finance and Bajaj Finance
Earnings laggards in Q2FY2017: Bank of India, IDBI Bank and Allahabad Bank
Banking and NBFCPace of slippage addition expected to moderate, treasury income to aid earnings
Sharekhan Special October 10, 20166
Sharekhan Special Q2FY2017 earnings preview
Valuation summary
Banks RecoPrice
Target (Rs)
CMP (Rs)
RoA (%) RoE (%) P/BV (x)
FY16 FY17E FY18E FY16 FY17E FY18E FY16 FY17E FY18E
PublicState Bank of India Buy 315 258 0.5 0.5 0.5 7.3 8.0 9.0 1.5 1.4 1.3Punjab National Bank Hold UR 143 -0.6 0.2 0.3 -10.3 4.2 5.7 0.8 0.8 0.7Bank of Baroda Buy 180 164 -0.8 0.3 0.3 -13.5 5.4 5.6 1.0 1.0 0.9Bank of India Hold 130 117 -1.0 0.1 0.2 -19.1 1.8 3.4 0.3 0.3 0.3Union Bank Hold 150 149 0.3 0.3 0.5 6.3 5.8 9.5 0.5 0.5 0.4Corporation Bank Reduce 30 43 -0.2 0.1 0.0 -4.6 1.6 0.0 0.4 0.4 0.4Allahabad Bank Hold 83 78 -0.3 0.3 0.3 -5.4 4.9 5.4 0.3 0.3 0.3IDBI Bank Hold UR 72 -1.0 0.2 0.3 -14.1 2.9 4.3 0.7 0.7 0.6PSBs total / avg. -0.3 0.3 0.3 -5.4 4.5 5.5 0.7 0.6 0.6PrivateICICI Bank Hold 290 251 1.4 1.6 1.7 11.4 12.6 14.2 1.7 1.5 1.4HDFC Bank Buy 1,415 1,281 1.9 1.9 1.9 18.3 19.1 20.1 4.5 3.9 3.3Axis Bank Hold 575 533 1.7 1.6 1.6 16.8 15.6 16.3 2.4 2.1 1.8Federal Bank Buy UR 73 0.5 0.7 0.9 6.0 9.4 11.5 3.2 1.5 1.3Yes Bank Buy 1,386 1,275 1.7 1.8 1.9 19.9 20.9 22.6 3.9 3.3 2.8Private banks total / avg. 1.4 1.5 1.6 14.5 15.5 16.9 3.1 2.4 2.1Grand total / avg. 0.6 0.9 0.9 4.6 10.0 11.2 1.9 1.5 1.4Soft CoverageIndusind Bank Positive NA 1.6 1.8 1.9 16.1 16.7 17.6 4.2 3.7 3.1L&T Finance Holding Positive NA 1.5 1.5 1.6 10.6 11.8 13.0 2.3 2.1 1.8NBFCsHDFC Ltd Buy 1,550 1,406 2.6 2.5 2.4 21.7 21.2 21.1 6.5 5.8 5.1LIC Housing Finance Buy 660 602 1.5 1.6 1.6 19.6 20.6 21.3 3.3 2.8 2.4Capital First Buy 840 742 1.3 1.5 1.6 10.1 13.2 16.7 4.0 3.5 3.1Bajaj Finance Buy 1,120 1,083 3.2 3.3 3.3 20.9 21.3 24.1 7.8 6.5 5.2PTC India Fin. Ser. Buy 55 39 5.0 3.2 3.2 24.6 18.0 20.3 1.3 1.1 1.0NBFCs Average 2.7 2.4 2.4 19.4 18.9 20.7 4.6 3.9 3.4UR - Under review
BanksNet interest income Pre-provisioning profit Profit after tax
Q2 FY17E
Q2 FY16
YoY %
QoQ %
Q2 FY17E
Q2 FY16
YoY %
QoQ %
Q2 FY17E
Q2 FY16
YoY %
QoQ %
PublicState Bank of India 14,618.4 14,252.6 2.6 2.1 10,591.1 10,265.9 3.2 -4.2 2,419.7 3,879.1 -37.6 -4.0Punjab National Bank 4,107.6 4,322.0 -5.0 11.0 2,837.1 2,938.5 -3.5 -13.4 422.7 621.0 -31.9 38.0Bank of Baroda* 3,475.6 3,244.5 7.1 3.1 2,779.7 2,337.0 18.9 4.1 559.8 124.5 349.7 32.1Bank of India 2,980.3 3,019.7 -1.3 7.4 1,337.6 1,458.3 -8.3 -19.1 -799.9 -1,126.2 NA 7.9Union Bank 2,053.6 2,101.7 -2.3 -2.3 1,541.5 1,490.1 3.5 -5.1 181.5 817.0 -77.8 9.1Corporation Bank 992.7 1,161.3 -14.5 -3.7 707.3 862.6 -18.0 -11.3 -65.5 188.6 NA NAAllahabad Bank 1,464.0 1,621.5 -9.7 5.1 1,024.6 1,158.8 -11.6 5.9 31.1 177.1 -82.4 -105.5IDBI Bank 1,492.7 1,611.8 -7.4 -12.5 1,432.6 1,518.8 -5.7 -2.3 96.4 119.5 -19.3 -60.0PSBs total 31,185.1 31,335.0 -0.5 2.6 22,251.5 22,029.9 1.0 -5.3 2,845.8 4,800.5 -40.7 19.2PrivateICICI Bank** 5,282.6 5,251.5 0.6 2.4 11,082.6 5,158.4 114.8 112.5 2,274.0 3,030.1 -25.0 1.9HDFC Bank 7,887.2 6,680.9 18.1 1.4 5,963.5 5,042.9 18.3 2.5 3,425.2 2,869.5 19.4 5.8Axis Bank 4,604.9 4,062.1 13.4 1.9 4,321.5 3,628.0 19.1 -3.3 1,692.1 1,915.6 -11.7 8.8Federal Bank 710.9 608.3 16.9 2.6 418.5 336.6 24.3 -1.7 184.5 161.3 14.4 10.3Yes Bank 1,361.0 1,108.5 22.8 3.3 1,286.0 1,019.1 26.2 -1.6 732.0 610.4 19.9 -0.1Private banks total 20,021.7 17,711.3 13.0 2.9 17,170.6 15,185.0 13.1 -0.4 7,868.4 8,586.9 -8.4 -0.7Grand total 36,407.6 34,793.8 4.6 2.4 28,458.2 26,949.0 5.6 -4.2 8,179.1 9,508.3 -14.0 4.9Soft CoverageIndusInd Bank 1,465.5 1,094.3 33.9 8.0 1,336.7 1,006.5 32.8 8.3 734.8 560.0 31.2 11.1L&t Finance 934.5 795.7 17.4 11.1 620.7 500.7 24.0 -9.4 231.2 215.4 7.3 11.5NBFCsHDFC 2,225.6 2,005.5 11.0 -0.2 2,649.1 2,277.7 16.3 -12.9 1,711.9 1,506.7 13.6 -8.5LIC Housing Finance 874.3 716.9 22.0 6.0 796.7 674.3 18.2 7.7 490.3 411.7 19.1 20.2Capital First 247.1 184.6 33.9 -11.1 159.1 109.4 45.4 -9.0 63.7 41.0 55.5 29.5Bajaj Finance 1,314.4 897.4 46.5 2.5 865.7 564.8 53.3 4.1 403.4 279.4 44.4 -4.9PTC India Fin. Ser.*** 103.9 94.1 10.4 4.5 109.3 308.4 -64.6 3.7 68.6 211.3 -67.5 1.7NBFCs Total 4,765.4 3,898.6 22.2 1.1 4,580.0 3,934.7 16.4 -6.4 2,737.9 2,450.1 11.7 -2.9* Q2FY2016 profits had declined significantly due to surge in NPAs resulting in higher provisions and interest reversal** Profit from stake sale through ICICI Preduntial Life IPO assumed to be utilised for NPA provisioning*** During Q2FY2016 profit had surged due to one-off income from sale of investment
Q2FY2017 estimates of Sharekhan’s banking and NBFC universe
Sharekhan Special October 10, 20167
Sharekhan Special Q2FY2017 earnings preview
Capital Goods and EngineeringOrder activity in select pockets; consumer segment momentum continues
Q2FY2017 result expectations
Mixed revenue growth for coverage companies; overall topline growth to touch double digits: We expect a wide variation in revenue growth across our coverage companies and hence see mixed topline in Q2FY2017. Among the heavyweights, we expect BHEL’s revenue to grow by 19% YoY and that of L&T to grow by 10% YoY in this quarter. Some of the smaller companies like Kalpataru Power Transmission (KPTL), Skipper and Triveni Turbines are expected to show strong growth. We highlight that Q2FY2016 numbers are subject to revision as per IND AS (which will be declared by the companies along with their Q2FY2017 results). We have taken actual (pre IND AS) numbers due to unavailability of IND AS numbers for Q2FY2016. In the case of Crompton Greaves (CGL), the Q2FY2016 numbers include business from discontinued operations. Therefore, the same would also be restated excluding the discontinued part (mainly International Power Systems business).
Strong bottomline performance likely; with better margins and lower interest costs: We expect an overall strong performance on the bottomline by most of our coverage companies, driven by better Operating Profit Margin (OPM) and drop in interest costs. Among the large companies, BHEL is expected to turn profitable from a loss in Q2FY2016 and L&T should report a healthy growth in comparable numbers (on revised Q2FY2016 numbers). In some of the smaller companies, we expect strong earnings growth in Q2FY2017. We estimate earnings of KPTL and V-Guard Industries to jump by 50% YoY and 38% YoY, respectively. V-Guard’s strong earnings growth would come from better margins while KPTL will get benefits from debt repayment and lower interest costs YoY. Other smaller companies like Finolex Cables, Skipper and Triveni Turbines are also likely to deliver earnings growth in the high teens.
Outlook
Domestic capex cycle mostly government driven; sustained traction in consumer business: We broadly bifurcate our coverage universe companies into Industrials (project oriented) and Consumers (product oriented). Clearly, the consumer-facing product-oriented companies have shown strong earnings traction in the last two quarters compared to project-centric companies. We believe that the project-oriented companies would be dependent on the revival of the domestic capex cycle. Although the capex cycle is yet to kick off on a secular basis, the government led capex should provide the push initially. The ordering activities continue in select areas like Power Transmission, Water, Solar Power, Road and Railways. Recently, OPEC agreed to cut oil production after almost eight years, which could give some stability to international oil prices, indirectly improving order inflow prospects from oil producing countries.
Valuation
View - Earnings performance will be key trigger: Driven by the favorable macro-economic factors like the impending GST implementation and the 7th Central Pay Commission (CPC) payouts to government employees, the consumer-facing businesses have been re-rated recently, supported by strong traction in earnings. Therefore, a healthy earnings growth expectation is already baked into the current stock prices for most of the consumer-centric companies. We believe that incremental earnings growth could drive the stock prices for these companies going forward. On the contrary, the project-oriented companies are yet to witness traction in order inflows. So, indications of better order inflows could be a key trigger for these companies. Overall, given the latest rate cut from the RBI, we expect interest sensitive companies to do well due to effectively lower interest costs in the near to medium term.
Preferred picks this earnings season: We prefer L&T in the large cap space while among the smaller companies we like KPTL, V-Guard, Triveni Turbines and Finolex Cables.
Q2FY2017E estimates Rs cr
Company Net sales (Rs cr) OPM (%) PAT (Rs cr)Q2FY17E YoY growth (%) Q2FY17E BPS (YoY) Q2FY17E YoY growth (%)
BHEL 6,952 19 1.6 NA 143 LTPCGL 1,439 -37 8.7 NA 32 LTPL&T 25,711 10 8.9 (217.6) 702 2KPTL (standalone) 1,207 27 10.8 (55.6) 62 50Thermax (standalone) 985 -7 8.0 (142.5) 57 -13Finolex Cables 620 2 12.7 21.0 77 19V-Guard Industries 493 14 10.0 157.7 32 38Va Tech Wabag 634 5 6.4 (84.7) 15 26Skipper 419 16 12.5 (263.0) 20 14Triveni Turbines 213 20 22.5 (99.3) 32 15Sharekhan coverage 38,671 8 7.8 58.6 1,171 61Ex-BHEL 31,719 6 9.1 (140.0) 1,028 10PL - Profit to loss; LTP- Loss to profit
Sharekhan Special October 10, 20168
Sharekhan Special Q2FY2017 earnings preview
Consumer Goods and ServicesSales volume yet to pick up; revenue growth to stay in single digits
Valuations
Company CMP (Rs) Reco PT (Rs)EPS (Rs) PE (x)
FY2016 FY2017E FY2018E FY2016 FY2017E FY2018E
BHEL 137 Reduce 141 (3.7) 0.5 4.2 NA NA 32.8
CGL 79 Reduce 70 2.0 3.4 3.7 39.4 23.2 21.3
L&T 1,456 Buy 1,640 50.8 56.4 67.5 28.7 25.8 21.6
KPTL # 253 Buy 320 13.0 17.7 20.0 19.4 14.3 12.6
Thermax # 915 Hold 920 25.6 24.4 26.3 35.7 37.5 34.8
Finolex Cables 449 Buy 500 16.3 18.0 20.3 27.6 25.0 22.1
V-Guard Industries 184 Buy 210 3.7 4.5 5.5 49.6 40.5 33.7
Va Tech Wabag 556 Buy 650 15.8 23.7 30.2 35.2 23.5 18.4
Skipper 156 Buy 190 8.1 9.4 11.5 19.3 16.6 13.6
Triveni Turbines 126 Buy 140 3.3 4.5 5.5 38.2 28.0 22.9
# stand-alone
Q2FY2017 result expectations
Revenue to grow in single digits; no major improvement in sales volume: With demand environment yet to pick up, the revenue growth for most of the FMCG companies under our coverage is expected to remain in single digits (volume growth is expected to stay in mid-single digits). The discontinuation of promotional offerings and judicious price hikes will add to overall revenue of most of the FMCG companies. HUL’s volume growth is expected to sustain at ~4-5% while we expect ITC’s cigarette business sales volume to grow by 1-2%. Volume growth of Britannia Industries, Marico and Jyothy Laboratories is expected to sustain in the range of 6-8%. The expected improvement in Household Insecticide (HI) category would support the overall revenue growth of Godrej Consumer Products (GCPL). Better demand for Automotive Paints and festival-related demand cheer would help Kansai Nerolac to post strong operating performance.
Margins to remain mixed: Higher prices of key commodities such as Palm Oil, Caustic Soda, Milk and Sugar would result in flat / marginal decline in Operating Profit Margin (OPM) of companies such as GCPL, GSK Consumer and Britannia. Though HUL’s gross margins are expected to remain flat, lower ad-spends and operating efficiencies would help in posting 60BPS YoY improvement in OPM. On the other hand, lower Copra and LLP prices would continue to provide margin benefits to companies such as Marico, Bajaj Corp and Emami.
Outlook
H2FY2017 is expected to see traction in volumes: With the southwest monsoon spreading out well and sustaining for a longer period, agriculture production (both Kharif and Rabi) is expected to be better than some of the previous years. This is likely to give boost to rural demand, which has remained muted for the past few quarters. Further, lower food inflation (Pulses and Vegetable prices have started correcting) and benefits from the implementation of the Seventh Central Pay Commission (CPC) would start reflecting from H2FY2017 amid improvement in urban consumption. On the other hand, the FMCG companies have taken measures to mitigate the impact from rising Raw Material (RM) prices by reducing promotional offerings and taking judicious price hikes in key brands. These measures, along with operating efficiencies would lead to stable OPM for most of the FMCG companies under our coverage. The introduction of GST will play a major role in the consumer sector in the long run.
Valuation
Consumer Goods companies continue to gain good acceptance among investors on the back of stable cash flows, sturdier balance sheets and improved earnings visibility in the long run. In the large-cap space, we continue to like HUL and ITC. In the mid-cap space, we continue to like Britannia, Emami, Manpasand Beverages and Kansai Nerolac. In the Consumer Services space, we continue to like Wonderla Holidays and Thomas Cook India.
Sharekhan Special October 10, 20169
Sharekhan Special Q2FY2017 earnings preview
Preferred picks: HUL, ITC, Britannia, Emami, Kansai Nerolac and Wonderla Holidays
Earnings outperformers in Q2FY2017: Britannia, Jyothy Laboratories, Kansai Nerolac and Zydus Wellness
Earnings underperformers in Q2FY2017: GSK Consumer and Emami
Sharekhan’s Consumer Goods and Services - Expected performance
CompaniesNet sales (Rs cr)
YoY (%) OPM (%) BPS
YoY (%)Adjusted PAT (Rs cr)
YoY (%)Q2FY17E Q2FY16 Q2FY17E Q2FY16 Q2FY17E Q2FY16
FMCG companies under coverageHUL 7,959.4 7,595.6 4.8 16.4 15.8 62 1,040.8 990.9 5.0ITC 9818.0 8,904.2 10.3 39.7 40.0 -29 2,691.9 2,431.3 10.7Britannia Industries 2,416.1 2,208.7 9.4 14.8 14.7 5 242.7 218.6 11.0GSK Consumer 1,097.0 1,074.7 2.1 16.4 17.4 -94 195.3 200.9 -2.8Emami 577.0 529.3 9.0 28.4 28.8 -38 105.7 109.8 -3.8GCPL 2,367.4 2,194.7 7.9 18.8 18.5 26 311.1 296.1 5.1Marico 1,507.6 1,453.0 3.8 17.6 15.8 177 174.8 147.0 18.9Jyothy Laboratories 445.6 401.4 11.0 14.3 12.3 205 35.1 23.0 52.5Zydus Wellness 116.9 105.3 11.0 25.8 25.6 23 33.2 29.7 11.9Under soft coverage Bajaj Corp 209.4 208.2 0.6 32.5 31.6 87 60.0 57.2 4.9Dabur India 2,126.9 2,090.1 1.8 18.9 18.7 18 331.4 312.9 5.9Kansai Nerolac 1,086.3 971.3 11.8 17.0 15.8 121 118.4 96.9 22.3Manpasand Beverages 114.6 81.5 40.6 17.4 19.6 -218 5.8 4.4 32.0Total 29,842.2 27,818.2 7.3 24.7 24.3 43 5,346.3 4,918.6 8.7Consumer Discretionary ServicesCox & Kings * 686.7 685.4 0.2 46.8 46.4 42 321.6 161.6 99Speciality Restaurants 78.3 79.7 -1.8 -0.1 4.8 -- -6.1 1.0 -Thomas Cook (India)# 2,343.5 964.8 - 5.7 5.2 53 58.1 17.2 238Wonderla Holiday 53.1 43.2 22.7 28.0 36.4 - 7.2 11.9 -40* Cox & Kings earnings estimates are not comparable on YoY basis due to hive-off of Superbreak business# Thomas Cook India YoY sales are not comparable due to change in the accounting standards
Valuations
Companies under coverage CMP (Rs)
EPS (Rs) PE (x)Reco.
Price Target (Rs)
FY16 FY17E FY18E FY16 FY17E FY18E
FMCG
HUL 878 19.3 22.0 26.2 45.5 39.9 33.5 Buy 995ITC 239 7.7 9.1 10.7 31.1 26.3 22.4 Buy 280Britannia Industries 3,392 69.3 83.5 100.0 49.0 40.6 33.9 Buy 3,950GSK Consumer 6,206 169.4 190.1 208.7 36.6 32.6 29.7 Hold 6,650Emami 1,157 23.3 26.9 35.8 49.6 43.0 32.3 Buy 1,300GCPL 1,629 31.9 38.7 46.9 51.1 42.1 34.7 Hold 1,690Marico 279 5.5 6.7 8.6 50.8 41.7 32.5 Hold 310Zydus Wellness 878 26.5 31.7 35.4 33.1 27.7 24.8 Buy 1,000Jyothy Laboratories 370 4.3 8.7 12.2 86.0 42.5 30.3 Buy 400Under Soft coverage Kansai Nerolac 382 6.7 8.1 9.7 57.4 47.3 39.3 Positive -Manpasand Beverages 732 10.1 16.2 26.0 72.5 45.2 28.2 Positive -Dabur India 283 8.0 9.3 10.5 35.4 30.6 27.0 NA -Consumer discretionary services Cox & Kings 224 16.8 18.3 25.1 13.3 12.2 8.9 Buy 250Thomas Cook India 201 0.8 3.3 6.1 254.6 61.5 33.1 Buy 255Speciality Restaurants 87 0.0 1.9 5.3 1766.1 44.4 16.4 Hold 115Wonderla Holidays 399 10.6 11.5 16.4 37.7 34.5 24.3 Buy 450
Sharekhan Special October 10, 201610
Sharekhan Special Q2FY2017 earnings preview
Cement Better utilisation to counter rising input cost
Q2FY2017 results estimates Rs cr
CompanySales OPM (%) PAT (Rs cr)
Q2 FY17E
Q2 FY16
YoY(%)
QoQ(%)
Q2 FY17E
Q2 FY16
YoY (BPS)
QoQ (BPS)
Q2 FY17E
Q2 FY16
YoY(%)
QoQ(%)
Coverage
Grasim 9,304 8,297 12.1 3.3 17.0 15.7 129 -456 584 488 19.5 -29.7
UltraTech Cement 5,904 5,621 5.0 -4.5 17.5 17.0 44 -471 480 424 13.4 -38.0
Shree Cement 2,273 2,017 12.7 2.2 25.3 25.0 26 -874 329 223 47.1 -35.3
The Ramco Cements 937 891 5.1 -3.7 28.8 32.6 -386 -251 130 127 2.5 -16.7
Soft coverage
India Cements 1,140 1,079 5.7 -5.4 17.6 21.2 -361 60 48 43 10.5 8.8
JK Lakshmi Cement 795 646 23.2 2.3 13.8 10.3 348 -137 21 -10 - -25.4
Mangalam Cement 203 200 1.7 -9.3 14.0 0.3 1380 -695 14 -16 - -40.0
Total 20,556 18,752 9.6 -0.2 18.5 17.9 59 -457 1606 1281 25.4 -32.1
Q2FY2017 result expectations
Higher volume, a marginal rise in realisations amidst increasing power cost: We expect the revenues of the cement companies under our coverage (active and soft) to increase by 9.6% in Q2FY2017 largely supported by an increase in the volume (due to an increase in capacity). On the realisation front, the northern and central regions have maintained pricing discipline where the prices are up by 14.7% and 9.8% YoY respectively (up 2.0% and 3.8% QoQ respectively). The western region shows a downtrend (down 4.5% YoY and 2.5% QoQ) while the southern and eastern regions display an uptrend in the prices sequentially although the prices are down 2.4% YoY. We expect cement players like UltraTech Cement, Shree Cement, JK Lakshmi Cement and Mangalam Cement to benefit from a higher volume growth along with a marginal rise in the realisations. However, the key monitorable would be the impact of a rise in the pet coke and imported coal prices on the OPM of the companies.
Southern players’ lower blended realisation YoY to be offset by higher volumes: This time around, the southern players have seen a sequential increase in the prices though the prices are still are down by 2.4% YoY. This is expected to result in a lower operating performance YoY for Q2FY2017. We expect India Cements and The Ramco Cements to be affected by the lower realisations. However, a better volume growth is expected to lead to an earnings growth.
Outlook
The northern and central belts have continued to sustain higher prices along with better capacity utilisation while we are yet to see pricing discipline in the south and an improvement in the utilisation levels. Going ahead, the demand is expected to pick up in H2FY2017 after a better monsoon, a pick-up in government infrastructure spending and a revival in rural demand. However, the input cost, which is on the rise, would be the key monitorable.
Valuation
Most of the players in the cement space continue to trade at higher valuation assuming a pick-up in demand. But we believe an increase in the input cost would remain a headwind in the near term. We remain selective in the cement space and advise you to enter it on correction.
Preferred picks this earnings season: Shree Cement, JK Lakshmi Cement and UltraTech Cement
Sharekhan Special October 10, 201611
Sharekhan Special Q2FY2017 earnings preview
Valuations
Company Reco CMP (Rs)EPS (Rs) PE (x)
FY16 FY17E FY18E FY16 FY17E FY18E
Shree Cement* Hold 17,865 136.2 455.7 581.2 131 39 31
UltraTech Cement Hold 3,963 80.9 108.5 131.3 49 37 30
Grasim Buy 4,928 253.8 325.3 399.8 19 15 12
The Ramco Cement Hold 628 22.4 23.8 29.6 28 26 21
India Cements# Cautious 156 4.6 11.8 17.2 34 13 9
JK Lakshmi Cement# Positive View 500 1.4 9.7 22.7 346 52 22
Mangalam Cement# Positive View 353 -7.7 13.7 23.8 - 26 15
UR – Under Review # soft coverage * Shree Cement M9FY2016, change in accounting year to March
ITSoft performance in a seasonally strong quarter
Q2FY2017 result expectations
Modest growth exacerbated by cross-currency headwinds: Despite the July-September quarter being a seasonally strong quarter historically for the IT sector, the USD revenue growth in Q2FY2017 will remain modest, owing to cross-currency headwinds (8% GBP depreciation vs USD), delay in ramp-up of large deals and lower discretionary spending in key verticals like Banking, Financial Services & Insurance (BFSI). We expect cross-currency headwinds (50-90BPS) to restrict USD revenue growth in the range of negative 0.3% to positive 2.8% (multi-year low Q2 growth), whereas the constant-currency (CC) revenue growth is expected to be in the range of 0.5% to 3.3%. On an organic basis, Infosys will be back on top of the IT pack with a CC revenue growth of 3.3%, followed by 2.8% for HCL Technologies (HCL Tech), 2.4% for Tata Consultancy Services (TCS), 3.1% (including inorganic) for Tech Mahindra (organic growth at 0.5%) and 0.5% for Wipro. On the operating margins front, we expect the OPM of top IT companies to be under pressure, owing to lower revenues, absence of rupee benefits, partial wage hikes (Wipro & HCL Tech) and integration/restructuring expenses (Wipro, HCL Tech & Tech Mahindra). However, we believe that Infosys and TCS would manage to expand OPM (40-50BPS) during Q2FY2017, driven by absence of wage hikes and higher visa costs.
Key issues to watch out for would be: (1) Trend in discretionary client spends in key verticals like BFSI, Telecom, Retail and Energy. In a recent press release (September 2016) TCS highlighted that the management foresees a sequential loss of momentum in its US BFS vertical (2) Demand environment outlook in FY2017E and commentary on macro headwinds. Infosys is likely to cut its FY2017 revenue growth guidance, owing to RBS deal cancellation and softness in spending by few clients due to Brexit. HCL Tech is expected to maintain its industry-leading FY2017 revenue growth guidance (3) Commentary on positioning in the digital/platforms/automation technologies and growth prospects in this space and (4) Commentary on margins and pricing (pressure on pricing is evident in deal renewals given the commoditisation of legacy services). We expect TCS to revise its targeted margin band of 26-28%, considering the cross-currency headwinds in Q2FY2017.
Outlook
Macro issues continue to remain overhang: Cross-currency headwinds, along with macro uncertainties are expected to drag the IT companies’ performance in Q2FY2017 - diluting the benefits of strong seasonality. However, we expect the overall industry growth to pick up momentum in the coming years, driven by higher capital allocation towards new-age digital technologies and traction in key verticals like ERD, Manufacturing etc. We maintain our stance that the IT industry is in a transition phase (investing and adding capabilities for newer technologies in the digital space) and modernising the best practices for its legacy business (which is gradually getting commoditised). This transition phase will take some time (~2-3 years) and would result in volatility in the earnings performance in the near to medium term.
Valuation
Inexpensive, but slower growth restricts upside: We believe that the overall CC revenue growth in FY2017E will be in high single digits on account of the anticipated 50-90BPS cross-currency headwinds in Q2FY2017, softness in key verticals like BFSI, weak discretionary spends, pricing pressure in legacy services and ongoing macro uncertainties. However, the demand environment is expected to improve gradually in FY2018E. We believe that lack of clarity on business impact from Brexit and the US presidential election rhetoric will restrict the stock outperformance in near to medium term, although stocks like Infosys, HCL Tech and Tech Mahindra are trading at inexpensive valuations.
Preferred picks: Infosys and HCL Tech (in large-cap space) and Persistent Systems (in mid-cap space). We maintain our cautious stance on IT sector.
Sharekhan Special October 10, 201612
Sharekhan Special Q2FY2017 earnings preview
Oil & gasGRM remains healthy; crude to get some respite
Q2FY2017 result expectations
Crude oil prices stable; cut in natural gas price: Crude oil prices improved slightly QoQ and remained around $46/bbl in Q2FY2017. The dollar remained fairly stable during the quarter. Therefore, we expect some improvement in the revenue of the upstream companies. We estimate crude oil revenue of Oil India Ltd (OIL) to be higher by 10% QoQ, mainly on account of a better realisation. However, we are building in flattish natural gas revenue for OIL, resulting in an 8% sequential improvement in the overall revenue of OIL in Q2FY2017. However, the domestic natural gas price has been revised down to $2.5/mmbtu from September this year which will push down the domestic gas realisation further from Q3FY2017 onwards.
Refining margin remains healthy; positive for refiners: During Q2FY2017, the benchmark Singapore gross refining margin (GRM) remained highly volatile swinging in a wide range between $3/bbl and $7/bbl. On an average, the Singapore GRM remained near $5.2/bbl, which is broadly in line with the last quarter’s level. Therefore, on a sequential basis, we expect the GRM to remain healthy in Q2FY2017. We expect Reliance Industries Ltd (RIL) to notch a hefty premium over that to touch a GRM of $10/bbl against $11.5/bbl in Q1FY2017. On the positive side, the petrochemical business would continue to perform well. Against this backdrop, we expect RIL to report earnings of Rs7,192 crore, 5% lower QoQ but 10% higher YoY in Q2FY2017.
Q2FY2017 results estimates
ParticularsSales (Rs cr) OPM (%) Net profit (Rs cr)
Q2 FY17E
Q2 FY16
YoY (%)
QoQ (%)
Q2 FY17E
Q2 FY16
YoY (BPS)
QoQ (BPS)
Q2 FY17E
Q2 FY16
YoY (%)
QoQ (%)
Infosys 17,230 15,635 10.2 2.7 27.0 27.8 (80) 53 3,559 3,398 4.7 3.6
TCS 29,677 27,166 9.2 1.3 27.2 28.8 (163) 42 6,314 6,055 4.3 0.0
Wipro 13,503 12,514 7.9 -0.7 18.9 21.8 (290) (60) 1,994 2,235 -10.8 -2.8
HCL Tech 11,591 10,097 14.8 2.2 21.8 21.9 (11) (45) 1,998 1,726 15.8 -2.4
Tech Mahindra 7,059 6,616 6.7 2.0 14.7 16.4 (170) (20) 712 838 -15.1 -5.1
Persistent Systems 723 543 33.2 3.0 15.0 18.7 (373) (5) 71 72 -0.9 -2.9
FSL 865 792 9.1 -3.2 12.6 12.4 22 (71) 67 62 8.4 -8.6
Source: Company, Sharekhan Research
Valuations
Company RecoPrice
target (Rs)
CMP (Rs)EPS (Rs) P/E (x)
FY16 FY17E FY18E FY16 FY17E FY18E
Infosys Buy 1,150 1,041 59.0 63.4 71.5 17.7 16.4 14.6
TCS Hold 2,450 2,383 122.9 133.3 147.1 19.4 17.9 16.2
Wipro Hold 590 478 36.2 37.5 42.0 13.2 12.7 11.4
HCL Tech* Buy 965 816 40.3 57.5 66.0 20.2 14.2 12.4
Tech Mahindra Neutral NA 425 36.3 37.0 41.5 11.7 11.5 10.2
Persistent Systems Buy 790 690 37.2 38.6 45.8 18.6 17.8 15.1
FSL Ltd Hold 52 40 3.8 4.7 5.7 10.7 8.6 7.1
*Changed its financial year ending from June-end to March-end during March 2016-ending quarterly results; hence, FY2016 consists only 9-month period Source: Company, Sharekhan Research
Sharekhan Special October 10, 201613
Sharekhan Special Q2FY2017 earnings preview
Q2FY2017 results estimates
CompanySales (Rs cr) OPM (%) PAT (Rs cr)
Q2 FY17E
Q2 FY16
YoY(%)
QoQ(%)
Q2 FY17E
Q2 FY16
YoY (bps)
QoQ (bps)
Q2 FY17E
Q2 FY16
YoY(%)
QoQ(%)
Coverage RIL 57,708 60,817 (5.1) 7.9 19.0 16.2 283 (122) 7,192 6,561 9.6 (4.7)Oil India 2,402 2,531 (5.1) 8.2 37.8 35.7 209 (104) 620 675 (8.2) 25.3Non-coverage GAIL 12,432 14,165 (12) 16 13 6 723 (169) 998 441 126 (25)ONGC 18,555 20,680 (10) 4 51 42 856 359 4,275 4,842 (12) 1
Valuations
Company CMP
EPS (Rs) CAGR over
FY16-18E (%)
PER (x)
Reco Price targetFY16 FY17E FY18E FY16 FY17E FY18E
Coverage
RIL 1,108 94 101 110 8.3 11.8 11.0 10.1 Buy 1,250
Oil India 414 42 33 40 (3.4) 9.8 12.4 10.5 Hold 400
Non-coverage
GAIL 420 18 27 33 36.8 23.7 15.3 12.6 NA NA
ONGC 265 19 19 26 17.2 14.2 13.9 10.3 NA NA
Outlook
The sector witnessed significant swings in the last 24 months. The prices of energy commodities (both crude and natural gas) corrected sharply and challenged many pre-existing dynamics. The Organization of Petroleum Exporting Countries (OPEC) seems to be contemplating a production cut, which could provide some stability to the global crude oil prices. However, the domestic natural gas price has been revised down by 18% to $2.5/mmbtu (NVC based) with effect from September 2016 which will significantly reduce the profitability of the gas production business of ONGC and OIL in the next quarter. While the domestic gas price cut would adversely affect the gas-producing upstream companies like ONGC, OIL and RIL, this could be a positive development for city gas distribution (CGD) players like Indraprasta Gas, Mahanagar Gas and Gujarat Gas. We believe the CGD players could retain some benefit, given the current situation where petrol and diesel prices are inching up and likely to remain firm in line with the global crude oil prices but domestic gas price is soft.
Valuation
We believe RIL will continue to outperform its peers, backed by a strong premium to the Singapore GRM and an improvement in the petrochemical business. Further, the launch of Reliance Jio has attracted significant attention and looks promising with extremely attractive offerings compared to peers. We retain our Buy rating on RIL. However, we retain our Hold rating on OIL and believe stability in oil prices could be a positive for OIL’s future earnings.
Preferred pick this earnings season: RIL
Sharekhan Special October 10, 201614
Sharekhan Special Q2FY2017 earnings preview
Q2FY2017 result expectations
Power generation in India is expected to grow by 2% YoY but decline by 3% QoQ to 289BU in Q2FY2017. During this quarter, we expect the energy deficit to be almost nil as more power was generated than required during Q2FY2017. Consequently, the merchant power prices are under pressure. In the meanwhile, the coal supply situation has improved.
We expect CESC to report a flattish earnings growth YoY due to both flat volume and average realisation during Q2FY2017. However, sequentially we expect the earnings to grow at 9%. The volumes are expected to be flat due to lower generation of power as the company has decided to strategically source more power from its new plant at Haldia. We expect CESC to report a PAT of Rs190 crore in Q2FY2017. On the other hand, PTC India is expected to witness a healthy volume growth (~16% YoY) and a flat average realisation. Hence, the top line is expected to grow at 15% to Rs4,062 crore. We expect the OPM per unit at 7 paise, which would translate into a PAT of Rs83 crore vs Rs101 crore in Q2FY2016. Among the non-rated companies, the consensus expects a 4% top line growth in NTPC and a 27% top line growth in Power Grid Corporation of India (owing to a sustained higher rate of capitalisation of assets). However, the earnings of NTPC are expected to decline while that of Power Grid Corporation of India are expected to remain healthy.
Outlook
The power sector has moved from one corner to another now, as the sector is likely to witness surplus thermal power generation capacity. That’s because the demand has not moved up meaningfully in the last couple of years while the capacity addition has remained steady in the same period. In the meanwhile, a major thrust is now on the renewable energy sector (with an aggressive capacity addition target from the central government). The unconventional power generation resources could pose a threat of disruption to the conventional plants in the long run. The state electricity board reform (the Ujwal DISCOM Assurance Yojana [UDAY]) is under way though some states need more time to comply. Among the coverage power companies, we retain a Hold on both CESC and PTC India with a price target of Rs 710 and Rs90 respectively.
Preferred stocks: PTC India, Power grid
Q2FY2017 results estimates
CompanySales (Rs cr) OPM (%) PAT Sales (Rs cr)
Q2 FY17E
Q2 FY16
YoY(%)
QoQ(%)
Q2 FY17E
Q1 FY16
YoY (BPS)
QoQ (BPS)
Q2 FY17E
Q2 FY16
YoY(%)
QoQ(%)
Coverage CESC 1,782 1,772 0.5 (6.8) 24.5 24.7 (18) 304 190 195 (2.4) 9.4 PTC India 4,062 3,521 15.4 11.5 2.2 1.6 59 39 83 76 8.3 62.1 Non-coverage NTPC 18,609 17,899 4.0 (1.7) 27.2 22.5 469 34 2,373 2,898 (18.1) 0.2 Power Grid 6,237 4,918 26.8 1.9 88.6 87.8 76 1 1,757 1,448 21.3 (2.5)
Valuations
Company CMP (Rs)
Book value per share CAGR over
FY16-18E (%)
PB (x)
Reco Price targetFY16 FY17E FY18E FY16 FY17E FY18E
Coverage CESC 625 651 691 702 4 1.0 0.9 0.9 Hold 710PTC India 76 94 99 105 6 0.8 0.8 0.7 Hold 90Non-coverage NTPC 146 108 115 124 7 1.4 1.3 1.2 NA NAPower Grid 178 82 93 106 14 2.2 1.9 1.7 NA NA
PowerA steady quarter
Sharekhan Special October 10, 201615
Sharekhan Special Q2FY2017 earnings preview
PharmaDecent performance; Stay selective with positive long-term outlook
Q2FY2017 result expectations
Benign quarter: In view of the improving domestic performance amid strong ‘acute’ season, most of the pharma
companies under our coverage are likely to report decent earnings growth during Q2FY2017. Also, a stable currency
environment and new drug approvals in Emerging Markets (EM) will support revenue and earnings growth. However,
revenue from the US business are likely to remain under pressure due to intensifying competition, pricing pressure
and lower exclusivity sales. We expect our pharma coverage universe to report revenue and profit growth of 12.5%
YoY and 22.5% YoY, respectively. Aggregate revenue growth of our coverage universe should be driven by strong
topline growth from companies like Aurobindo Pharma (15% YoY) and Lupin (29.4% YoY). Profit growth of our coverage
universe should be driven by robust growth in the bottomline of companies like Aurobindo (19% YoY), Glenmark
Pharma (22.3% YoY), Lupin (99.3% YoY) and Sun Pharma (47.7% YoY).
Improvement in profitability: We expect the Operating Profit Margin (OPM) of our coverage universe to expand by
109.6BPS YoY, underpinned by a better product mix and improved operational efficiencies. Net profit of our coverage
universe is likely to grow by 22.5% YoY in Q2FY2017 due to lower tax outflow.
USFDA remediation update to be key monitorable: Some of the key companies like Cipla, Cadila Healthcare, Dr
Reddy’s, Lupin and Sun Pharma continue to witness pressure in the US business (excluding exclusivity sales), as the
unresolved USFDA issues have affected new drug approvals. We should closely watch this quarter’s earnings and the
management commentary on USFDA remediation updates, which could lead to upgrades / downgrades.
In terms of our pharma coverage universe, while Aurobindo, Glenmark, Lupin and Sun Pharma are likely to post
good earnings growth, Cipla is likely to report marginal decline. Torrent Pharma (due to significant decline in
contribution from Abilify) is likely to post a significant fall in its Q2F2017 earnings.
Outlook & Valuation
Positive long-term outlook; stay selective: Recent announcements of closure of initial round of 483 observation
forms have lifted some pressure from the Indian Pharma sector. Therefore, we continue to remain positive on the
long-term prospects of the sector and advise to stay selective. We also see headwinds on account of USFDA warning
letters getting resolved in the near term.
Preferred picks this earnings season: Aurobindo, Glenmark and Sun Pharma
Earnings outperformers in Q2FY2017: Glenmark, Lupin and Sun Pharma
Earnings laggards in Q2FY2017: Cipla and Torrent Pharma
Sharekhan Special October 10, 201616
Sharekhan Special Q2FY2017 earnings preview
Valuations
Company
CMP (Rs) Reco
EPS (Rs) PE (x) RoCE (%)
FY16 FY17E FY18E FY16 FY17E FY18E FY16 FY17E FY18E
Aurobindo 857 Buy 35.0 44.9 59.0 24.5 19.1 14.5 27.9 29.4 33.1
Cadila 387 Hold 14.9 18.3 22.1 26.0 21.1 17.5 28.3 28.5 31.3
Cipla 579 Hold 19.5 21.3 27.5 29.7 27.2 21.1 14.2 14.5 17.4
Divis 1,273 Hold 41.9 46.2 57.2 30.4 27.6 22.3 30.8 32.3 32.9
Glenmark 922 Buy 37.8 51.5 54.8 24.4 17.9 16.8 19.6 23.8 23.0
Lupin 1,485 Hold 50.4 67.4 84.1 29.5 22.0 17.7 18.7 22.2 25.6
Sun Pharma 753 Buy 22.4 30.4 33.8 33.6 24.8 22.3 20.3 23.5 24.2
Torrent Pharma 1,640 Hold 110.0 71.6 81.3 14.9 22.9 20.2 50.8 26.5 24.3
Sharekhan’s pharma companies’ expected performance
ParticularsNet sales (Rs cr) OPM (%) Adjusted PAT (Rs cr)
Q2 FY17E
Q2 FY16
YoY (%)
QoQ (%)
Q2 FY17E
Q2 FY16
YoY (BPS)
QoQ (BPS)
Q2 FY17E
Q2 FY16
YoY (%)
QoQ (%)
Under coverage
Aurobindo* 3,832.0 3,333.0 15.0 2.8 24.3 23.3 103.3 44.4 608.0 510.0 19.2 5.4
Cadila 2,632.0 2,460.0 7.0 3.5 23.3 25.3 -196.2 -3.8 405.0 391.0 3.6 0.0
Cipla 3,788.0 3,452.4 9.7 5.4 19.0 22.9 -389.9 195.3 420.5 431.0 -2.4 15.2
Divis 1,060.0 964.3 9.9 5.1 38.6 39.0 -40.7 -147.1 299.2 295.7 1.2 -0.9
Glenmark 2,161.0 1,909.4 13.2 11.2 20.5 21.0 -54.4 98.9 242.0 197.8 22.3 6.7
Lupin 4,296.0 3,321.0 29.4 -3.2 30.4 20.2 1,017.4 94.6 815.0 409.0 99.3 -7.6
Sun Pharma 7,609.0 6,838.0 11.3 -7.7 32.8 28.3 451.1 -264.6 1,635.0 1,106.7 47.7 -19.6
Torrent Pharma 1,539.2 1,655.0 -7.0 2.1 29.0 43.1 -1,416.6 -2.2 298.4 515.0 -42.1 2.2
Total - A 26,917.2 23,933.1 12.5 -0.3 27.4 26.3 109.6 -58.1 4,723.1 3,856.2 22.5 -7.1
Under soft coverage
Biocon 950.6 828.2 14.8 5.2 24.5 22.8 172.7 -4.4 147.0 103.1 42.6 -0.1
Dr Reddy's Lab 3,416.0 3,989.0 -14.4 6.0 15.0 27.0 -1,199.9 289.1 273.0 693.4 -60.6 86.7
Granules India 392.1 366.4 7.0 14.1 20.4 18.8 164.2 30.0 37.0 31.0 19.5 16.2
Natco 329.0 235.0 40.0 1.2 24.0 19.5 451.4 24.4 49.0 29.2 67.9 3.4
Total - B 5,087.7 5,418.6 -6.1 6.1 21.0 22.0 -102.9 195.9 506.0 856.7 -40.9 35.8
Grand Total (A+B) 32,004.9 29,351.7 9.0 0.7 24.2 24.1 3.3 -27.6 5,229.1 4,712.9 11.0 -4.2
*Aurobindo’s profit in Q2FY16 is adjusted for forex loss of Rs57 crore
Sharekhan Special October 10, 201617
Sharekhan Special Q2FY2017 earnings preview
Miscellaneous
Q2FY2017 results estimates
CompanyNet Sales (Rs cr) OPM (%) Adjusted PAT (Rs cr)
Q2FY17E Q2FY16 YoY (%) QoQ (%)
Q2FY17E Q2FY16 YoY (BPS)
QoQ (BPS)
Q2FY17E Q2FY16 YoY (%)
QoQ (%)
Bharti Airtel 24,279.5 23,851.9 1.8 -5.1 37.2 34.6 261 -23 1,221.0 1,505.5 -18.9 -16.5
UPL 3,275.0 2,815.9 16.3 -7.6 20.0 18.6 140 10 319.0 228.8 39.4 -22.0
PI Industries 535.5 446.1 20.0 -16.2 21.0 19.0 200 -490 76.3 53.8 41.8 -39.9
BEL 1,525.7 1,467.7 3.9 75.1 9.5 12.0 -245 - 162.6 206.8 -21.4 -
Zee Entertainment 1,633.7 1,384.9 18.0 3.9 28.0 25.6 239 -84 324.3 280.3 15.7 -1.8
Inox Leisure 297.0 307.4 -3.4 -11.8 11.0 18.2 - -743 7.5 20.1 -62.7 -70.0
Info Edge 201.1 174.1 15.5 1.8 24.4 19.2 525 22 44.2 33.9 30.3 -0.4
Supreme Industries 849.7 772.8 9.9 -28.6 15.1 11.7 335 -181 55.6 32.0 73.8 -45.3
Gateway Distriparks* 74.0 67.1 10.3 -7.0 24.9 33.0 - 476 11.4 14.2 -20.0 17.3
IRB Infrastructure 1,457.4 1,149.2 26.8 -4.0 50.7 52.6 -195 -32 170.1 149.1 14.0 -6.5
Gayatri Projects 372.3 317.2 17.4 -13.9 16.1 15.8 27 204 7.6 7.3 4.9 -31.3
ITNL* 1,214.4 1,129.5 7.5 4.7 21.1 22.0 -86 -63 -35.8 74.9 - -
Raymonds 1,589.3 1,491.6 6.6 50.3 8.4 9.0 -60 502 40.3 34.4 17.2 -
Kewal Kiran Clothing 161.0 141.1 14.2 50.5 27.0 26.5 51 - 28.9 24.1 19.6 129.0
Relaxo Footwear 401.7 386.3 4.0 -7.4 14.4 13.2 114 -189 27.5 24.1 13.8 -24.2
Century Plyboard 485.2 442.2 9.7 19.6 16.1 16.7 -65 -79 49.5 46.3 7.0 15.0
Orbit Exports 39.3 41.4 -5.3 5.7 33.6 34.6 -100 55 7.6 8.5 -10.8 3.3
KDDL 113.8 108.4 5.0 6.7 7.6 8.7 -114 183 3.5 5.3 -33.7 -* Standalone financials
Sharekhan Limited, its analyst or dependant(s) of the analyst might be holding or having a position in the companies mentioned in the article.
For Private Circulation only
Disclaimer
This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. Kindly note that this document is based on technical analysis by studying charts of a stock’s price movement and trading volume, as opposed to focusing on a company’s fundamentals and as such, may not match with a report on a company’s fundamentals.(Technical specific) This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
The analyst certifies that the analyst has not dealt or traded directly or indirectly in securities of the company and that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. The analyst further certifies that neither he nor his relatives has any direct or indirect financial interest nor have actual or beneficial ownership of 1% or more in the securities of the company nor have any material conflict of interest nor has served as officer, director or employee or engaged in market making activity of the company. Further, the analyst has also not been a part of the team which has managed or co-managed the public offerings of the company and no part of the analyst’s compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document.
Either SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind.
Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; For any queries or grievances kindly email igc@sharekhan.com or contact: myaccount@sharekhan.com
Registered Office: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai – 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Registration details: BSE – INB/INF/INE011073351; NSE – INB/INF/INE231073330; MSEI: INB/INF-261073333, CD - INE261073330; DP-NSDL-IN-DP-NSDL-233-2003; CDSL-IN-DP-CDSL-271-2004; PMS-INP000000662; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do’s & Don’ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing.